{"id":100358,"date":"2024-11-25T13:58:25","date_gmt":"2024-11-25T12:58:25","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/"},"modified":"2024-11-25T13:58:25","modified_gmt":"2024-11-25T12:58:25","slug":"gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/","title":{"rendered":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic"},"content":{"rendered":"

Aelix Therapeutics<\/a> -una spinoff de IrsiCaixa<\/a>, presente en el Parque Cient\u00edfico de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para tratar la infecci\u00f3n por VIH- ha anunciado hoy la adquisici\u00f3n por parte de Gilead Sciences<\/a> de sus activos de investigaci\u00f3n relacionados con la vacuna terap\u00e9utica HTI contra el VIH, que tiene el potencial de convertirse en la primera inmunoterapia capaz de controlar y eliminar la infecci\u00f3n provocada por el virus de manera eficiente.<\/strong><\/p>\n

El inmun\u00f3geno HTI, que constituye la base de esta vacuna terap\u00e9utica, fue dise\u00f1ado en IrsiCaixa por el investigador\u00a0Christian Brander<\/strong>\u00a0y las investigadoras\u00a0Beatriz Mothe<\/strong>\u00a0y\u00a0Anuska Llano,\u00a0<\/strong>en el marco del programa HIVACAT y con el apoyo de la Fundaci\u00f3n Gl\u00f2ria Soler. Posteriormente, AELIX lo desarroll\u00f3 cl\u00ednicamente, alcanzando resultados prometedores en ensayos cl\u00ednicos de fase 1 y 2.<\/p>\n

El inmun\u00f3geno HTI fue concebido para redirigir la respuesta inmunitaria hacia las regiones m\u00e1s vulnerables del VIH, un enfoque estrat\u00e9gico que busca superar las limitaciones de las terapias actuales.<\/p>\n

Christian Brander<\/strong>, investigador ICREA en IrsiCaixa y director cient\u00edfico de AELIX, se\u00f1ala que \u201cver c\u00f3mo este inmun\u00f3geno se incorpora ahora a la estrategia de una compa\u00f1\u00eda farmac\u00e9utica tan innovadora como Gilead Sciences es un gran avance en la b\u00fasqueda de una posible estrategia de cura del VIH\u201d.<\/p>\n

Seg\u00fan Thomas Hecht,<\/strong> presidente ejecutivo de AELIX: \u00abEstamos encantados de que una compa\u00f1\u00eda del nivel de Gilead haya decidido adquirir los activos de investigaci\u00f3n relacionados con la vacuna terap\u00e9utica HTI de AELIX contra el VIH. Las vacunas HTI han mostrado resultados prometedores en los ensayos cl\u00ednicos de fase 1 y fase 2, y estamos deseando ver avanzar este inmun\u00f3geno en su desarrollo gracias a esta adquisici\u00f3n y, potencialmente, convertirse en una pieza clave en la b\u00fasqueda de una cura para el VIH. Estamos muy agradecidos a nuestros inversores iniciales, como Ysios Capital, que tuvieron la visi\u00f3n de apoyar el desarrollo de posibles estrategias para la curaci\u00f3n del VIH\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"

Aelix Therapeutics -una spinoff de IrsiCaixa, presente en el Parque Cient\u00edfico de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para tratar la infecci\u00f3n por VIH- ha anunciado…<\/p>\n","protected":false},"author":14,"featured_media":100236,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-100358","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ciencia"],"acf":[],"yoast_head":"\nGilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Aelix Therapeutics -una spinoff de IrsiCaixa, presente en el Parque Cient\u00edfico de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para tratar la infecci\u00f3n por VIH- ha anunciado...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T12:58:25+00:00\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic\",\"datePublished\":\"2024-11-25T12:58:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/\"},\"wordCount\":361,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BeaAnuskaChristian_Aelix.png\",\"articleSection\":[\"CIENCIA\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/\",\"name\":\"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BeaAnuskaChristian_Aelix.png\",\"datePublished\":\"2024-11-25T12:58:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BeaAnuskaChristian_Aelix.png\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BeaAnuskaChristian_Aelix.png\",\"width\":1238,\"height\":454},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/","og_locale":"es_ES","og_type":"article","og_title":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona","og_description":"Aelix Therapeutics -una spinoff de IrsiCaixa, presente en el Parque Cient\u00edfico de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para tratar la infecci\u00f3n por VIH- ha anunciado...","og_url":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2024-11-25T12:58:25+00:00","author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic","datePublished":"2024-11-25T12:58:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/"},"wordCount":361,"image":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/11\/BeaAnuskaChristian_Aelix.png","articleSection":["CIENCIA"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/","url":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/","name":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/11\/BeaAnuskaChristian_Aelix.png","datePublished":"2024-11-25T12:58:25+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/11\/BeaAnuskaChristian_Aelix.png","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/11\/BeaAnuskaChristian_Aelix.png","width":1238,"height":454},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/gilead-adquiere-los-activos-de-la-vacuna-contra-el-vih-de-aelix-therapeutic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Gilead adquiere los activos de la vacuna contra el VIH de AELIX Therapeutic"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/100358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=100358"}],"version-history":[{"count":0,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/100358\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/100236"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=100358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=100358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=100358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}